LTRN

LTRN

USD

Lantern Pharma Inc. Common Stock

$3.590-0.110 (-2.973%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$3.700

High

$3.700

Low

$3.550

Volume

0.00M

Company Fundamentals

Market Cap

39.0M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.05M

Exchange

NCM

Currency

USD

52-Week Range

Low $2.55Current $3.590High $7.21

Related News

Analyst Upgrades

Lake Street Initiates Coverage On Lantern Pharma with Buy Rating, Announces Price Target of $25

Lake Street analyst Chad Messer initiates coverage on Lantern Pharma with a Buy rating and announces Price Target of $25.

View more
Lake Street Initiates Coverage On Lantern Pharma with Buy Rating, Announces Price Target of $25
BusinessWire

Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results

HARMONIC™ trial lead-in cohort delivered impressive 86% clinical benefit rate and 43% objective response rate in never-smoker NSCLC patients, with current expansion cohort reinforcing these positive trends as

View more
Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results